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Radiographic Abnormalities
and Asbestos Exposure:
Libby, Montana 
Peipins et al. (2003) described the study
conducted by the Agency for Toxic
Substances and Disease Registry (ATSDR
2001, 2002a) to analyze the association
between the prevalence of radiographic
abnormalities and asbestos exposure path-
ways for residents of Libby, Montana.
Although Peipins et al. presented many
detailed results, they failed to explicitly state
the obvious conclusion of their analysis:
excess risk of asbestos-related disease for
Libby residents is a consequence of occupa-
tional exposure, and risk associated with
low-level exposure is negligible. This find-
ing is extremely important for guiding
future public health assessments of exposure
to vermiculite from the Libby mine and
exposure to amphibole asbestos in general.
Peipins et al. (2003) made a clear case for
the importance of occupational exposure.
They reported the following statistically sig-
nificant factors for predicting pleural abnor-
malities: being a former mine worker; being
older; having been a household contact of a
mine worker; and being male. These results
associate pleural abnormalities with high
occupational exposure groups—mine
workers and household contacts of mine
workers. Only one environmental exposure
pathway was statistically significant—
played in vermiculite pile, which may
involve exposures as high as occupational
exposures.
The ATSDR data (ATSDR 2001,
2002a) indicate that 17.8% of the 6,668
subjects with X-ray films had pleural abnor-
malities. This percentage appears large in
comparison to 6.7% of subjects with
pleural abnormalities in the internal control
group (no exposure). However, occupa-
tional exposures inflate the difference.
I reanalyzed the data by forming three
exposure groups: mine workers, residents
with other occupational or domestic expo-
sure, and residents with no occupational or
domestic exposure (the “environmental
exposure only” group) (Price B. In press).
Pleural abnormalities were recorded for 51%
of mine workers, 19.9% of residents with
other occupational or domestic exposure,
and 9.1% of residents with no occupational
or domestic exposure.
These results again demonstrate the
importance of occupational exposure for
pleural abnormalities. The percentage for
the “environmental exposure only” group is
close to the percentage for the internal con-
trols. Other confounding factors mentioned
by Peipins et al. (2003) could further reduce
the difference. One of those factors is the
false positive bias due to subpleural fat,
which would be expected to be greater in
the environmental exposure group than in
the mine worker group (Price B. In press).
Peipins et al. (2003) implied that
asbestos exposure was high in Libby:
Air sampling in downtown Libby in 1975 and at
several points in the 1980s detected levels well
above the Occupational Safety and Health
Administration’s [OSHA] occupational limit of
0.1 fiber/cm3 over 8 hr of exposure (Atkinson et
al. 1982; Dixon et al. 1985; U.S. Department of
Labor 1994).
However, the cited references do not con-
tain data for samples collected in 1975.
Dixon et al. (1985) reported that a total of
four stationary samples were collected, each
for 2 hr (Atkinson et al. 1982). These sam-
ples, analyzed by two laboratories, produced
the following measurements, respectively:
0.08 and 0.50 fiber/cm3, 0.10 and
0.02 fiber/cm3, 0.03 fiber/cm3 and none
detected, and 0.03 and 0.02 fiber/cm3.
Comparison of these 2-hr sampling results
to OSHA’s 8-hr limit is not meaningful.
Also, because the measurements vary con-
siderably between laboratories, the largest
measurement is not a reliable estimate of
exposure in Libby.
Recently, the U.S. Environmental
Protection Agency (U.S. EPA 2001, 2002)
measured airborne asbestos levels in Libby
and estimated exposure for Libby residents
engaged in activities that disturbed house-
hold dust, vermiculite attic insulation, and
soil. The results, stated as lifetime average
daily exposure, ranged from 0.00007 to
0.005 fiber/cm3. Risk levels calculated by
the U.S. EPA for these exposures were
between 1 × 10–6 and 1 × 10–4, the accept-
able range defined by the U.S. EPA (1989)
for regulatory decisions.
The study described by Peipins et al.
(2003) is one of a number of studies
addressing asbestos exposure and risk in
Libby (Amandus and Wheeler 1987;
ATSDR 2000, 2001, 2002a, 2002b;
McDonald 2001; McDonald et al. 1986;
McDonald JC. Unpublished data; U.S. EPA
2001, 2002). The perception that mine
workers’ disease rates apply to all Libby resi-
dents gained credibility through the
ATSDR (2000) asbestosis mortality study:
“… mortality in Libby resulting from
asbestosis was approximately 40–60 times
higher than expected.” Later, the ATSDR
(2002b) explained that the excess mortality
was a consequence of occupational exposure.
As noted by Peipins et al. (2003), the
ATSDR observed a total of 12 asbestosis
deaths: 11 males who were previously
employed at the Libby mine and 1 female
who was a household contact of a mine
worker.
The results presented by Peipins et al.
(2003) and results from other studies of
asbestos in Libby indicate that occupational
exposure—not low-level environmental
exposure—is the most significant risk factor
for asbestos-related disease. Peipins et al.
should have stated that conclusion explicitly,
taking the first step toward correcting mis-
perceptions about asbestos disease in Libby
and, more generally, the risk of disease asso-
ciated with low-level exposures to amphibole
asbestos.
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Radiographic Abnormalities:
Response from Peipins et al.
We appreciate Price’s interest in our article
(Peipins et al. 2003). We stated clearly that
being a former W.R. Grace (WRG) worker
was a significant risk factor for both pleural
and interstitial abnormalities. We also noted
that only age was more strongly associated
with these outcomes in multivariate analyses
and that these results were not unexpected. 
However, we disagree with Price’s state-
ment that the obvious conclusion of our
analysis is that risk associated with low-level
environmental exposure is negligible. Such a
conclusion ignores key results. For example,
we found that playing in the vermiculite
piles and longer duration of residence in
Libby, Montana, were associated with
pleural abnormalities, even after controlling
for occupational and domestic exposures
(Peipins et al. 2003). We also found that the
prevalence of pleural abnormalities increased
with increasing number of exposure path-
ways, even after we removed WRG workers
from the analysis. This suggests a cumulative
effect from multiple exposures that exclude
working in the mine. 
Price incorrectly labels our “no-apparent-
exposure” group as an “internal control
group.” We did not have an internal no-
exposure group (Peipins et al. 2003). Our
no-apparent-exposure group consisted of
participants who responded “no” to the
exposure pathways listed in the questionnaire
and who were likely exposed via ambient air
and other pathways not assessed by our
screening questionnaire. The rate of 6.7%
for the no-apparent-exposure group in our
analysis and the rate of 9.1% given by Price
in his letter are considerably higher than the
prevalence rates of pleural abnormalities
found in published studies of other nonoccu-
pationally exposed populations in the United
States, which range from 0.2% among blue-
collar workers in North Carolina (Castellan
et al. 1985) to 2.3% among patients at
Veterans Affairs hospitals in New Jersey
(Miller and Zurlo 1996). Of note, these
studies did not exclude family contacts of
workers or domestic exposures (Castellan
et al. 1985; Anderson et al. 1979). 
When assessing subpleural fat as a con-
founding factor, we found former WRG
workers to have higher body mass indexes
(BMIs) than those who were not former
WRG workers. We controlled for subpleural
fat by including BMI in both our multivari-
ate analyses and our pathways analyses.
Therefore, the associations between environ-
mental exposures, as well as occupational
and domestic exposure, and pleural abnor-
malities remained when controlled for BMI. 
In regard to Price’s comments on past
exposures in Libby, sampling performed by
WRG in 1975 showed markedly elevated
ambient air asbestos concentrations in
downtown Libby [U.S. Environmental
Protection Agency (EPA 2002)]. These
findings are consistent with the limited
ambient air samples collected by the U.S.
EPA (Dixon et al. 1985; Atkinson et al.
1982). Although Price points out that the
variation in detectable laboratory results
ranged from 0.02 to 0.5 fiber/cm3, depend-
ing on the laboratory, it is clear that the
ambient air concentrations in Libby easily
approached, if not exceeded, occupational
8-hr limits. In a cross-sectional study of
workers at an Ohio fertilizer plant that
processed vermiculite from Libby, Montana,
Lockey et al. (1984) found that workers with
daily time-weighted-average exposures of
0.031–0.415 fiber/cm3, similar to the ambi-
ent air concentrations reported in Libby, had
significantly elevated radiographic pleural
changes and pleuritic chest pain.
Price asserts that Agency for Toxic
Substances and Disease Registry (ATSDR)
mortality studies conducted for the Libby
area have created a false perception of the
community’s asbestos-related mortality expe-
rience. Results from ATSDR’s mortality
study (ATSDR 2002) revealed significantly
elevated rates of mesothelioma, asbestosis,
and lung cancer when compared with the
Montana and U.S. populations. Workers
were included in the determination of
asbestos-related mortality in Libby, as is done
as a matter of practice throughout the nation
to determine comparative standardized mor-
tality rates. Nevertheless, there were several
deaths found that did not appear to be occu-
pationally related. Notably, one of the three
mesothelioma cases identified for inclusion in
our study (Peipins et al. 2003) did not occur
among former mine workers (ATSDR 2002).
Additionally, Lincoln County, Montana, had
the highest age-adjusted asbestosis mortality
rate in the United States for 1988–1997,
even when compared to other counties that
contain large asbestos exposed workforces
(Castellan R. Unpublished data). 
On the basis of our results, we conclude
that both occupational and environmental
risk factors are important predictors of
asbestos-related radiographic abnormalities
in this community. We thank Price for his
comments and hope that this letter provides
additional insights to these issues.
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of Radiographic Abnormalities
“Radiographic Abnormalities and Exposure
to Asbestos-Contaminated Vermiculite in
the Community of Libby, Montana, USA”
by Peipins et al. (2003) is the first journal
publication by the Agency for Toxic
Substances and Disease Registry (ATSDR)
of the results of their multiyear medical
testing program of Libby residents. Peipins
et al.’s (2003) conclusion that 18% of study
participants had pleural abnormalities has
received wide attention and has lead to
understandable concern among Libby resi-
dents and health professionals. We, as prin-
cipals of Health Network America (HNA)
and administrators of the Libby Medical
Plan (LMP), are in the unique position of
having participated in the peer review of
applicants and members of the LMP. The
LMP is a health benefit program for the peo-
ple who lived in and around Libby and
developed an asbestos-related condition. The
peer reviewers include two board-certified
radiologists who specialize in chest radiogra-
phy and/or pneumoconiosis and are certi-
fied B-readers, and a third board-certified
radiologist who specializes in interpretation
of pleural disease on chest computed tomog-
raphy (CT) scans. Although the review
process is ongoing, some of our preliminary
observations are relevant because they
include many cases reported as “abnormal”
by the ATSDR. In this letter we seek to
communicate the more serious issues raised
by this review process.
The basic ATSDR study design included
a three-view chest X ray (posterior–anterior,
left and right, and obliques) on all partici-
pants over 18 years of age, with the X rays to
be interpreted by three B-readers. If two of
the B-readers identified a pleural or interstitial
abnormality, this would be regarded as a pos-
itive response by the ATSDR. If only one of
the initial two B-readers identified an abnor-
mality, the third B-reader also performed an
interpretation.
Several problems are raised by this
design. First, all B-readers were aware that
the X rays were of Libby residents, opening
the door to reader bias. Second, the B-read-
ers knew the sequence in which they
reviewed the films. B-readers 1 and 2 knew
they were always the first or second reader.
B-reader 3, then, not only knew the X rays
were from Libby but also had the reports of
B-readers 1 and 2 prior to making his
interpretation. Although control films or a
control group would have been useful in
resolving these issues, they were not used. 
Peipins et al. (2003) bolstered their
findings with the assertion that “if two out
of three B-readers indicated…,” implying
agreement between these readers. The
HNA’s review (HNA. Unpublished data)
reveals that in many instances this was not
the case. For example, if one reader found a
potential pleural plaque on the right chest
wall and the second reader recorded a possi-
ble pleural plaque on the left chest wall or
diaphragm, this was apparently recorded as
a positive finding of an abnormality by two
B-readers. These discrepancies were not
reported by the ATSDR to study partici-
pants or by Peipins et al. (2003).
Perhaps the most troubling issue in the
study by Peipins et al. (2003) is the misread-
ing of plaques or thickening when only
pleural fat was present. While acknowledging
the confounding influence of obesity and
pleural fat in determining pleural disease,
Peipins et al. (2003) failed to scientifically
account for this. The ATSDR (2001)
reported that the body mass indexes (BMIs)
of 67% of the 7,307 participants were ≥ 25,
indicating overweight, and 32% of these
were obese (BMI of ≥ 30). We indepen-
dently verified the true incidence of over-
weight and obesity by calculating BMIs of
the LMP participants: 89% were overweight
and 54% were obese (Table 1).
Peipins et al. (2003) conceded that 
a heavier BMI can make it more difficult to dis-
tinguish between pleural abnormalities and sub-
pleural or extraplural fat ...
This difficulty was clearly present in their
study. As part of the HNA review, X rays
and CT scans of study participants were sent
for peer review as described above. Although
this review is continuing, it is clear that in
many cases, participants coded as positive
for pleural changes either had no visible
asbestos-related changes on their X rays or
they had subpleural fat that was misdiag-
nosed as pleural thickening or plaques. 
As a result of the study bias, non-
conformity of the B-reader reports, and not
accounting for high BMIs and pleural fat,
the study by Peipins et al. (2003) markedly
overstated the consequences of asbestos
exposure in Libby, Montana. 
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Overstating the Consequences:
Peipins et al.’s Response
Flynn et al. raise concerns about differences
in chest radiograph interpretation and bias
among B-readers in our study (Peipins et al.
2003). Furthermore, they suggest that an
internal review by Health Network America
(HNA) found misdiagnosis in many cases,
with subpleural fat being miscoded as
asbestos-related pleural changes.
In the Libby, Montana, screening pro-
gram, all films were reviewed by at least two
experienced B-readers, with a third B-reader
functioning as a “tiebreaker” to settle dis-
agreements. Participants were categorized as
“positive” if two B-readers reported any
pleural abnormality, and as “indeterminate”
if only one B-reader reported an abnormal-
ity. For clinical purposes, participants in
both the “positive” and the “indeterminate”
categories were notified and encouraged to
follow up with their personal physician.
The three B-readers are respected experts in
the field and are distinguished members of
academic institutions. Furthermore, the
design of the screening program employed
is similar to that used in previous studies of
asbestos-related radiographic abnormalities
(Rogan et al. 1987, 2000).
Although the B-readers in the screening
program were aware that the X rays were
from the Libby area, they had no other
information about occupational or environ-
mental exposure pathways and were blinded
to the identities of individuals who were
screened. This is important because a clear
exposure–response relationship was docu-
mented between the presence of pleural
abnormalities and the number of exposure
pathways reported by participants. Only
6.7% of the group with “no apparent expo-
sure” had pleural abnormalities, compared
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Table 1. BMIs from LMP applicant and member
data (n = 341).
BMI No. (%)
≥ 40 23 (7)
30–39.9 160 (47)
25–29.9 120 (35)
<2 5 38 (11)to 10.8% of the group reporting one to
three exposure pathways, 14.4% of the
group reporting four to five exposure path-
ways, and 23.7% of the group reporting six
or more pathways. This trend remained sig-
nificant even after controlling for body mass
index in the multivariate analysis. 
We recently evaluated preliminary data
from high resolution chest computed
tomography (CT) scans conducted on
353 Libby medical screening participants
with “indeterminate” chest radiographs.
Pleural abnormalities were identified in
98 persons (28% of all tested) whose chest
radiographs were classified as “indetermi-
nate” (i.e., only one out of three B-readers
noted an abnormality). This suggests that
the results of the Libby screening program
may have actually underestimated the
number of abnormal findings. 
In summary, we disagree with Flynn
et al.’s assertion that these findings can be
explained by study bias issues related to
chest radiograph B-readings or by misinter-
pretation of pleural fat. Rather, more recent
high-resolution CT scanning results suggest
that our estimates of pleural abnormalities
in this population may be conservative and
may actually underestimate the true preva-
lence of these abnormalities seen on chest
radiographs.
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Expert Witnesses Need to
Know About the New Risks
Professionals should not enter into provid-
ing witness or consulting services without
considering their personal liabilities. I
would like to provide some recent changes
and liability issues for the consideration of
expert witnesses and consultants.
Times change, as does the law. Under
recent court decisions, an expert witness
whose work fails to meet professional stan-
dards may find himself/herself being hauled
back into court as a defendant in a malprac-
tice claim. If the expert knows of possible per-
sonal weaknesses, hiring additional experts to
cover these weak areas is a feasible solution. 
Historically, witnesses could not be sued
for defamation on the basis of their testimony
in court. The law granted this immunity to
encourage candid testimony, or as one court
put it, “to ensure that the path to truth is left
as free and unobstructed as possible.”
In 1999, however, the Supreme Court
of Pennsylvania carved a large exception out
of the immunity doctrine for expert wit-
nesses. In the case of LLMD of Michigan,
Inc. v. Jackson-Cross Co. (1999), the court
held that a client could sue his expert wit-
ness for negligence if the expert fails to exer-
cise the care and skill common to his
profession in forming his opinions on the
client’s case. 
In 2002, the Supreme Court of Appeals
in West Virginia took the issue further in
Davis v. Wallace (2002) when it suggested
that an expert witness could be sued for neg-
ligence not only by his own client but also by
the opposing party against whom the expert
testifies. Experts need to keep up with their
fields of interest in the era of rapid new
information. This can be done by reading,
attending meetings, and talking with other
experts. Publishing articles in peer-reviewed
journals can help document and prove exper-
tise to the judge. Keeping good records,
which display knowledge through good writ-
ing skills, is critical; many decisions are based
on written documents. Continuing educa-
tion courses are available to improve the
expert’s practice and avoid liability problems.
Also, all communications should be carefully
edited before they are sent.
Scientists who serve as expert witnesses
in federal lawsuits should be prepared to jus-
tify their theories and methods used in each
case in a Daubert hearing. This is a layman’s
shorthand reference to the 1993 U.S.
Supreme Court decision in Daubert v.
Merrell Dow Pharmaceuticals, Inc. (1993).
The Daubert case radically altered the rules
for expert witnesses in federal court. For
most of the twentieth century, federal courts
were supposed to permit expert witnesses to
offer scientific evidence at trial only if the
scientific principles involved were generally
accepted within their field. In the Daubert
case, the Supreme Court held that the gen-
eral acceptance test was too restrictive and
was not compatible with modern rules of
evidence. 
On one hand, the Daubert case (Daubert
v. Merrell Dow Pharmaceuticals, Inc. 1993)
opened the courthouse door to novel scien-
tific evidence. On the other hand, this case
vested trial judges with a gatekeeping role to
weed out “irrational pseudoscientific asser-
tions,” or to separate cutting-edge principles
from “junk science” (Daubert v. Merrell
Dow Pharmaceuticals, Inc. 1993). As part
of their gatekeeping function, judges are
required to make a preliminary assessment
to determine whether the expert’s theory or
technique has been and can be tested,
whether it has been subject to peer review
and publication, and whether the theory or
technique has a known or potential rate of
error.
Courts have not established hard and
fast rules on the manner in which they will
decide Daubert objections. The process
could be as simple as the lawyers submitting
documents to the judge, or it could involve
a form of mini-trial in which the court
hears testimony from the expert and other
experts who attempt to validate or discredit
the expert’s theories and practices at issue.
What should scientists do, knowing that
their work as expert witnesses may be
rejected by a judge and knowing that their
own clients may sue them if the case turns
out badly? Some experts may decide that it
is not worth the liability exposure and may
decline invitations to serve as an expert wit-
ness. But doing good, reliable, legally defen-
sible work is the best way a scientist can
survive a Daubert challenge.
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Validation of (Q)SARs Models
From a practitioner’s point of view (but
not having been part of the workshop), I
feel compelled to comment on “Summary
of a Workshop on Regulatory Acceptance
of (Q)SARs for Human Health and
Environmental Endpoints” by Jaworska
et al. (2003).
There are a variety of quantitative struc-
ture–activity relationships [(Q)SARs] models
available for a variety of purposes, and, as
stated by Jaworska et al. (2003), predictive
power is a critical issue in evaluating any
model. Regrettably, the accompanying arti-
cles by Eriksson et al. (2003) and Cronin et
al. (2003a, 2003b) fail to mention any of the
recent publications on the application of
probabilistic neural networks (PNNs) for the
modeling of toxicity endpoints. Highly effec-
tive PNN models have been demonstrated
for the fathead minnow (Kaiser and
Niculescu 1999), the waterflea Daphnia
magna (Kaiser and Niculescu 2001a), the cil-
iate Tetrahymena pyriformis (Niculescu et al.
2000), the Microtox bacterium Vibrio fis-
cheri (Kaiser and Niculescu. In press), and
estrogen receptor binding affinity (Kaiser
and Niculescu 2001b). Indeed, Moore et al.
(2003) have shown that fathead minnow
PNN has superior performance in essentially
all aspects when compared to the other
methods. Other types of neural networks
have similarly been shown to be robust and
to provide optimal predictions (e.g., Burden
and Winkler 1999). Furthermore, commer-
cially available programs using PNN
methodology have recently become available
for the estimation of several toxicologic end-
points, such as fathead minnow 96-hr
median lethal concentrations (LC50)
(TerraBase, Inc. 2002), rat and mouse intra-
venous LD50 (TerraBase, Inc. 2003a), and
estrogen receptor binding affinity
(TerraBase, Inc. 2003b). 
Although representativity or domain of
a model are good concepts in theory, they
are difficult to define or use in practice.
Moreover, the statistical descriptors of a
model’s performance—such as goodness of
fit, specificity, sensitivity, transparency, and
similarity—are often misleading because the
applied data set(s) for many (Q)SARs are
narrow, skewed, or otherwise nonrepresenta-
tive of the chemical world existing in reality.
In most cases, a model user cannot ascertain
whether a particular model may or may not
be used for a particular compound and end
point to be estimated. Without tests of com-
parative performance, this conundrum exists
for users of most models. Even for quite
similar compounds, model outputs can vary
by several orders of magnitude between both
models and measured values. For example,
predictions of octanol/water partition coeffi-
cients (a physical property) for a small set of
quite similar compounds by commonly used
models show a large divergence of values
(Vrakas et al. 2003). Therefore, the (only)
proof of model accuracy is in the testing of
each model’s performance against a broad
spectrum of measured data, which are not
part of the training set of each model. In
practice, this means that performance of a
model should be the driving force for its
acceptability in the regulatory world, not its
statistics. 
Regular scrutiny of performance has
been commonplace in other areas. For exam-
ple, the performance of Canadian environ-
mental analytical laboratories is regularly
checked with round robin testing. The pre-
dictive power of carcinogenicity and muta-
genicity models has been evaluated in several
rounds of testing, with the biological testing
subsequent to the models’ predictions. There
is a great need for such comparative testing
of the usefulness of various existing (Q)SAR
models. The valiant performance testing of
several toxicity-prediction (Q)SARs models
by Moore et al. (2003) shows some surpris-
ing results and further gives credence to this
thought. Indeed, Jaworska et al. (2003) also
stress the need for an independent organiza-
tion to validate data and models irrespective
of any model’s claims. 
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Validation of (Q)SARs Models:
Jaworska et al.’s Response
We warmly welcome and agree with the
comments from Kaiser. In writing the
reports that comprised the Mini-Monograph
on “Regulatory Acceptance of (Q)SARS”
published in EHP and also during the work-
shop sponsored by the International Council
of Chemical Associations and the European
Chemical Industry Council and held in
Setubal, Portugal, in March 2002 (Jaworska
et al. 2003), it was never our stated or under-
lying intention to make a thorough review of
(Q)SARs for toxicologic endpoints and fate.
This has been more than adequately
achieved in recent editions of Environmental
Toxicology and Chemistry (2003) and the
Journal of Molecular Structure-THEOCHEM
(THEOCHEM 2003). This is firmly stated
in the papers themselves (Cronin et al.
2003a, 2003b; Eriksson et al. 2003). Instead,
the purpose of these articles was to review the
use of (Q)SARs to predict toxicity and fate
by regulatory bodies. However, it should be
understood, that such reviews will be needed,
and are ongoing, in order for (Q)SARs to
find a more extensive and transparent use in
regulatory schemes and thus achieve their
stated goal of reducing animal testing. In
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sgeneral, only predictive techniques used by
regulatory bodies are mentioned, although
some other work to illustrate various other
techniques was cited to provide examples.
We did state that the probabilistic neural
network (PNN) provided the best predic-
tions for fish toxicity on the basis of an
external test set (Cronin et al. 2003a), but
like the vast majority of examples of
(Q)SARs in the literature, the other end-
points were not included. With regard to
the article by Eriksson et al. (2003), the
scope was clearly defined in the title; that is,
it provided an assessment of regression- and
projection-based methods. There are also
other approaches to (Q)SAR, such as sup-
port vectors machines; however, these were
not included because they are not used
broadly in all (Q)SAR disciplines. Further,
these techniques are not in frequent use by
regulatory bodies. 
We agree with Kaiser that the perfor-
mance of a model should be a driving force
and is more important than statistics.
Appropriate measures of predictivity or per-
formance are enshrined in the cornerstones of
current attempts at validation. As part of the
validation process, the domain of applicabil-
ity should also be defined. This will allow a
user to know whether a prediction is likely to
be valid. It should also be noted that Eriksson
et al. (2003) explain that representativity and
homogeneity are basic requirements for
(Q)SAR modeling, regardless of the statistical
method used to develop the model. Eriksson
et al. (2003) also noted that these concepts
were easy to check and accomplish. Provided
the basic conditions of representativity and
homogeneity are not violated, statistical
descriptors of a model’s performance are not
misleading. Indeed, failure to comply with
representativity and homogeneity will result
in the statistical assessment of model perfor-
mance becoming inappropriate.
The reality is that simple and transparent
models are (on the whole) favored by regula-
tory bodies over more opaque approaches,
even if it means losing some statistical fit. We
understand that problems could arise in some
PNN approaches that have used large num-
bers of descriptors, some with no relevance to
the mechanism of action (Cronin and Schultz
2001). A further issue with PNNs is the fact
that they do not provide the same numerical
solution to a problem when repeated.
The goal of the Setubal workshop was to
encourage further development of the
(Q)SAR sciences toward practical use and
application. It is important, that as these
models develop into more efficient tools for
society to understand the fate and effect of
chemicals, without extensive use of animals
and other resources, they be seen to be valid
and suitable for the purpose. To achieve this
goal, there are a number of ongoing attempts
to validate (Q)SARs (e.g., at the European
Union and the Organisation for Economic
Co-operation and Development level). These
will attempt to weigh all the evidence and
produce scientifically sound and usable vali-
dation techniques. Interested parties are
encouraged to join in these efforts. More
information is available on the European
Commission Joint Research Centre website
(JRC 2003).
The authors declare they have no competing
financial interests.
Joanna S. Jaworska
Procter & Gamble Eurocor
Strombeek-Bever, Belgium 
E-mail: jaworska.j@pg.com
Mark Cronin
Liverpool John Moores University
Liverpool, United Kingdom
Lennart Eriksson
Umetrics
Umea ˚, Sweden
Mike Comber
ExxonMobil
Brussels, Belgium
REFERENCES
ETC. 2003. Environ Toxicol Chem 22(8):1651–1936.
Cronin M, Schultz TW. 2001. Development of quantitative
structure-activity relationships for the toxicity of aromatic
compounds to Tetrahymena pyriformis: comparative
assessment of the methodologies. Chem Res Toxicol
14:1284–1295.
Cronin MTD, Walker JD, Jaworska JS, Comber MHI,
Watts CD, Worth AP. 2003a. Use of QSARs in interna-
tional decision-making frameworks to predict ecological
effects and environmental fate of chemical substances.
Environ Health Perspect 111:1376–1390.
Cronin MTD, Jaworska JS, Walker JD, Comber MHI, Watts CD,
Worth AP. 2003b. Use of QSARs in international decision-
making frameworks to predict human health effects.
Environ Health Perspect 111:1391–1401.
Jaworska JS, Comber M, Auer C, Van Leeuwen CJ. 2003.
Summary of the workshop on regulatory acceptance of
(Q)SARs. Environ Health Perspect 111:1358–1360.
JRC. 2003. QSARS. Ispra, Italy:European Commission, Joint
Research Centre. Available: http://ecb.jrc.it/QSAR/
[accessed 2 Dec 2003].
Erriksson L, Jaworska J, Worth AP, Cronin MTD, McDowell
RM, Gramatica P. 2002. Methods for reliability and
uncertainty assessment and for applicability evaluations
of classification and  regression-based QSARs. Environ
Health Perspect 111:1361–1375.
THEOCHEM. 2003. J Mol Structure 622(1–2):1–184.
Environmental Health Perspectives • VOLUME 112 | NUMBER 2 | February 2004 A 87
Correspondence
Correction
In the January Forum article “Tidal
Turbines: Wave of the Future?” [EHP
112:A26 (2004)], Bjørn Bekken was
incorrectly quoted as saying, “Once we
pass peak production of fossil fuels, the
difference between supply and demand
decreases day by day and energy prices
will go up.” What Bekken in fact said
was that the difference between supply
and demand increases day by day. EHP
regrets the error.